Falcon Therapeutics
Chapel Hill, US · Founded 2015 · North Carolina corporation
Founders & leadership
MG
Matthew G. EwendNamed on SEC filing
AM
Anna M. SealNamed on SEC filing
SD
Shawn D. HingtgenNamed on SEC filing
KJ
Karen J. GirouxNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$700K disclosed across 1 round · 2017
▶$700KraisedJun 2017 · 2 investors · BiotechnologyRule 506(b)
▶$700KraisedJun 2017 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Matthew G. EwendDirector
- Anna M. SealExecutive Officer, Director
- Shawn D. HingtgenDirector
- Karen J. GirouxExecutive Officer, Director
- Offering amount
- $700K
- Amount sold
- $700K
- First sale
- Jun 2017
- Incorporated
- Corporation, North Carolina, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Falcon Therapeutics raised?
- Falcon Therapeutics has disclosed $700K raised across 1 round.
- Where is Falcon Therapeutics headquartered?
- Falcon Therapeutics is headquartered in Chapel Hill, US.